Business Context and Reporting Period
This Form 8-K Current Report was filed by Palisade Bio, Inc. on September 13, 2021. The filing serves as a Regulation FD disclosure to announce the release of a revised corporate presentation, which is attached as Exhibit 99.1. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol PALI.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate presentation rather than a financial statement filing (such as a 10-K or 10-Q).
Material Changes
The material change reported is the issuance of a revised corporate presentation. The filing explicitly states that the information contained in the presentation is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, and it shall not be deemed incorporated by reference into other filings unless specifically stated by the Company.
Guidance, Outlook, and Risks
While the filing references a corporate presentation that likely contains management commentary and outlook, the text of this 8-K does not summarize specific guidance, risks, contingencies, or unusual items. Investors must refer to the attached Exhibit 99.1 for those details.
Key Facts for Investor Verification
- Verify the contents of the revised corporate presentation attached as Exhibit 99.1 for updated business strategy and financial projections.
- Note that the information in this filing is not subject to the liabilities of Section 18 of the Exchange Act.
- Confirm the company's status as an emerging growth company (indicated by the checkmark in the filing) and any associated reporting exemptions.
- Review the company's principal executive offices located at 5800 Armada Drive, Suite 210, Carlsbad, California.